Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Histological and histomorphometric effects of ibandronate on the metaphyseal spongiosis in tibia were studied in tail-suspended rats and their controls in a 30-d experiment. Ten- to twenty-day course of ibandronate at a dose of 6 micrograms/kg of the body mass per diem altered the architectonics of metaphyseal spongiosis and increased materially the total spongiosis volume no matter whether those were suspended rats or controls. Spongiosis growth was a result of a sharp deterioration of resorption and spongy bone remodelling due to ibandronate. The substance also exhibited a strong durable action inferring that it might be used for prevention of osteopenia for lack of loading on the musculoskeletal system.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!